Form 4: Neurocrine Biosciences Director Reports Stock Transaction
Insider Transaction (Form 4)
Stephen A Sherwin, a Director of Neurocrine Biosciences Inc, reported a transaction in 1,000 shares of common stock on September 2, 2026.
Summary
- Bona fide gift: disposed of 1,000 Common Stock on September 2, 2026; holds 14,860 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Stephen A Sherwin — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-02 | Bona fide gift | Common Stock | 1,000 | — | — | 14,860 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-02 | Bona fide gift (1,000 shares) |
Keywords
insider transaction, Form 4, NBIX, NEUROCRINE BIOSCIENCES INC, neutral, Stephen A Sherwin
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.